Atrás
Rango del Día
$17.21
$17.88
Rango de 52 Semanas
$10.96
$21.49
Volumen
599,773
Promedio 50D / 200D
$19.13
/
$16.82
Cierre Anterior
$17.15
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -42.3 | 0.4 |
| P/B | 3.0 | 2.9 |
| ROE % | -6.3 | 3.7 |
| Net Margin % | -5.6 | 3.9 |
| Rev Growth 5Y % | 6.4 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$23.33
+32.9%
Low: $18.00
High: $26.00
EPS Futuro
-$0.07
Ingresos Est.
430 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$0.70
$0.69 – $0.70
|
530 M | 1 |
| FY2027 |
$0.28
$0.26 – $0.30
|
480 M | 4 |
| FY2026 |
-$0.07
-$0.07 – -$0.07
|
430 M | 4 |
Puntos Clave
Revenue grew 6.40% annually over 5 years — modest growth
Earnings declined -140.64% over the past year
Debt/Equity of 0.06 — conservative balance sheet
Generating 36.12M in free cash flow
PEG of 0.34 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.39%
Crecimiento
Revenue Growth (5Y)
6.40%
Revenue (1Y)13.79%
Earnings (1Y)-140.64%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-6.27%
ROIC-4.88%
Net Margin-5.62%
Op. Margin-5.53%
Seguridad
Debt / Equity
0.06
Current Ratio2.86
Interest Coverage0.00
Valoración
P/E Ratio
-42.29
P/B Ratio2.98
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.79% | Revenue Growth (3Y) | 16.40% |
| Earnings Growth (1Y) | -140.64% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 6.40% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 379.81M | Net Income (TTM) | -21.35M |
| ROE | -6.27% | ROA | -5.17% |
| Gross Margin | 66.99% | Operating Margin | -5.53% |
| Net Margin | -5.62% | Free Cash Flow (TTM) | 36.12M |
| ROIC | -4.88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.06 | Current Ratio | 2.86 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -42.29 | P/B Ratio | 2.98 |
| P/S Ratio | 2.38 | PEG Ratio | 0.34 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 903.16M | Enterprise Value | 857.41M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 379.81M | 333.79M | 280.32M | 321.79M | 296.40M |
| Net Income | -21.35M | 52.55M | -190.28M | -76.61M | -30.66M |
| EPS (Diluted) | -0.40 | 0.93 | -3.54 | -1.44 | -0.59 |
| Gross Profit | 254.43M | 224.16M | 178.33M | 209.58M | 199.01M |
| Operating Income | -21.02M | 40.77M | -203.36M | -77.23M | -29.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 413.23M | 491.05M | 466.83M | 542.99M | 566.62M |
| Total Liabilities | 110.13M | 112.62M | 205.50M | 112.08M | 100.75M |
| Shareholders' Equity | 303.10M | 378.43M | 261.33M | 430.91M | 465.88M |
| Total Debt | 19.68M | 28.37M | 34.22M | 39.00M | 21.35M |
| Cash & Equivalents | 65.43M | 114.69M | 82.20M | 89.92M | 348.49M |
| Current Assets | 257.13M | 351.83M | 313.71M | 387.85M | 433.36M |
| Current Liabilities | 89.85M | 89.37M | 78.07M | 75.98M | 77.30M |